The inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy
The aim of the research project discussed in this thesis was to study the inhibition of aerobic glycolysis, that is the metabolic pathway exploited by cancer cells for the ATP generation. This observation has led to the evaluation of glycolytic inhibitors as potential anticancer agents. Lactate dehy...
Main Author: | |
---|---|
Other Authors: | |
Format: | Doctoral Thesis |
Language: | en |
Published: |
Alma Mater Studiorum - Università di Bologna
2014
|
Subjects: | |
Online Access: | http://amsdottorato.unibo.it/6195/ |
id |
ndltd-unibo.it-oai-amsdottorato.cib.unibo.it-6195 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-unibo.it-oai-amsdottorato.cib.unibo.it-61952014-04-04T04:48:37Z The inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy Vettraino, Marina Eleonora <1983> MED/04 Patologia generale The aim of the research project discussed in this thesis was to study the inhibition of aerobic glycolysis, that is the metabolic pathway exploited by cancer cells for the ATP generation. This observation has led to the evaluation of glycolytic inhibitors as potential anticancer agents. Lactate dehydrogenase (LDH) is the only enzyme whose inhibition should allow a blocking of aerobic glycolysis of tumor cells without damaging the normal cells which, in conditions of normal functional activity and sufficient oxygen supply, do not need this enzyme. In preliminar experiments we demonstrated that oxamic acid and tartronic acid, two LDH competitive inhibitors, impaired aerobic glycolysis and replication of cells from human hepatocellular carcinoma. Therefore, we proposed that the depletion of ATP levels in neoplastic cells, could improved the chemotherapeutic index of associated anticancer drugs; in particular, it was studied the association of oxamic acid and multi-targeted kinase inhibitors. A synergistic effect in combination with sorafenib was observed, and we demonstrated that this was related to the capacity of sorafenib to hinder the oxidative phosphorylation, so that cells were more dependent to aerobic glycolysis. These results linked to LDH blockage encouraged us to search for LDH inhibitors more powerful than oxamic acid; thus, in collaboration with the Department of Pharmaceutical Sciences of Bologna University we identified a new molecule, galloflavin, able to inhibit both A and B isoforms of LDH enzyme. The effects of galloflavin were studied on different human cancer cell lines (hepatocellular carcinoma, breast cancer, Burkitt’s lymphoma). Although exhibiting different power on the tested cell lines, galloflavin was constantly found to inhibit lactate and ATP production and to induce cell death, mainly in the form of apoptosis. Finally, as LDH-A is able to bind single stranded DNA, thus stimulating cell transcription, galloflavin effects were also studied on this other LDH function. Alma Mater Studiorum - Università di Bologna Di Stefano, Giuseppina 2014-01-23 Doctoral Thesis PeerReviewed application/pdf en http://amsdottorato.unibo.it/6195/ info:eu-repo/semantics/openAccess |
collection |
NDLTD |
language |
en |
format |
Doctoral Thesis |
sources |
NDLTD |
topic |
MED/04 Patologia generale |
spellingShingle |
MED/04 Patologia generale Vettraino, Marina Eleonora <1983> The inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy |
description |
The aim of the research project discussed in this thesis was to study the inhibition of aerobic glycolysis, that is the metabolic pathway exploited by cancer cells for the ATP generation. This observation has led to the evaluation of glycolytic inhibitors as potential anticancer agents. Lactate dehydrogenase (LDH) is the only enzyme whose inhibition should allow a blocking of aerobic glycolysis of tumor cells without damaging the normal cells which, in conditions of normal functional activity and sufficient oxygen supply, do not need this enzyme. In preliminar experiments we demonstrated that oxamic acid and tartronic acid, two LDH competitive inhibitors, impaired aerobic glycolysis and replication of cells from human hepatocellular carcinoma. Therefore, we proposed that the depletion of ATP levels in neoplastic cells, could improved the chemotherapeutic index of associated anticancer drugs; in particular, it was studied the association of oxamic acid and multi-targeted kinase inhibitors. A synergistic effect in combination with sorafenib was observed, and we demonstrated that this was related to the capacity of sorafenib to hinder the oxidative phosphorylation, so that cells were more dependent to aerobic glycolysis. These results linked to LDH blockage encouraged us to search for LDH inhibitors more powerful than oxamic acid; thus, in collaboration with the Department of Pharmaceutical Sciences of Bologna University we identified a new molecule, galloflavin, able to inhibit both A and B isoforms of LDH enzyme. The effects of galloflavin were studied on different human cancer cell lines (hepatocellular carcinoma, breast cancer, Burkitt’s lymphoma). Although exhibiting different power on the tested cell lines, galloflavin was constantly found to inhibit lactate and ATP production and to induce cell death, mainly in the form of apoptosis. Finally, as LDH-A is able to bind single stranded DNA, thus stimulating cell transcription, galloflavin effects were also studied on this other LDH function.
|
author2 |
Di Stefano, Giuseppina |
author_facet |
Di Stefano, Giuseppina Vettraino, Marina Eleonora <1983> |
author |
Vettraino, Marina Eleonora <1983> |
author_sort |
Vettraino, Marina Eleonora <1983> |
title |
The inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy |
title_short |
The inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy |
title_full |
The inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy |
title_fullStr |
The inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy |
title_full_unstemmed |
The inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy |
title_sort |
inhibition of aerobic glycolysis as a therapeutic approach to improve cancer chemotherapy |
publisher |
Alma Mater Studiorum - Università di Bologna |
publishDate |
2014 |
url |
http://amsdottorato.unibo.it/6195/ |
work_keys_str_mv |
AT vettrainomarinaeleonora1983 theinhibitionofaerobicglycolysisasatherapeuticapproachtoimprovecancerchemotherapy AT vettrainomarinaeleonora1983 inhibitionofaerobicglycolysisasatherapeuticapproachtoimprovecancerchemotherapy |
_version_ |
1716662726599639040 |